The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy
Open accessAbstract
BACKGROUND: Autoimmune retinal degeneration may occur in patients who present with sudden or, less commonly, subacute loss of vision of retinal origin, associated with an abnormal ERG, through the action of autoantibodies against retinal proteins. Often the patients are initially diagnosed with or suspected of having a paraneoplastic retinopathy (PR), such as cancer-associated retinopathy (CAR). However, there is limited information on the occurrence, the specificity of autoantibodies in these patients, and their association with clinical symptoms. METHODS: Sera were obtained from 193 retinopathy patients who presented with clinical symptoms resembling PR or autoimmune retinopathy (AR), including sudden painless loss of vision, typically associated with visual field defects and photopsias, and abnormal rod and/or cone responses on the electroretinogram (ERG). Sera were tested for the presence of anti-retinal autoantibodies by Western blot analysis using proteins extracted from human retina and by immunohistochemistry. Autoantibody titers against recoverin and enolase were measured by ELISA. RESULTS: We identified a higher prevalence of anti-retinal autoantibodies in retinopathy patients. Ninety-one patients' sera (47.1%) showed autoantibodies of various specificities with a higher incidence of antibodies present in retinopathy patients diagnosed with cancer (33/52; 63.5%; p = 0.009) than in retinopathy patients without cancer (58/141; 41.1%). The average age of PR patients was 62.0 years, and that of AR patients was 55.9 years. Autoantibodies against recoverin (p23) were only present in the sera of PR patients, autoantibodies against unknown p35 were more common in patients with AR, while anti-enolase (anti-p46) autoantibodies were nearly equally distributed in the sera of patients with PR and those with AR. In the seropositive patients, the autoantibodies persisted over a long period of time--from months to years. A rebound in anti-recoverin autoantibody titer was found to be associated with exacerbations in visual symptoms but not in the recurrence of cancer. When compared to sera from healthy subjects, autoantibodies against retinal proteins from both groups of patients were cytotoxic to retinal cells, indicating their pathogenic potential. CONCLUSIONS: These studies showed that patients with sudden or subacute, unexplained loss of vision of retinal origin have anti-retinal antibodies in a broad range of specificity and indicate the need for autoantibody screening. Follow-up tests of antibody levels may be useful as a biomarker of disease activity associated with worsening of vision. Moreover, the heterogeneity in autoantibody specificity may explain the variation and complexity of clinical symptoms in retinopathy patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Keltner, J. L., Thirkill, C. E., & Yip, P. T. (2001) · Journal of Neuro-Ophthalmology · doi:10.1097/00041327-200109000-00004 · Cited by 258
Thirkill, C. E., FitzGerald, P., Sergott, R. C., Roth, A. M., Tyler, N. K., & Keltner, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912073212307 · Cited by 242
Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy.
Milam, A. H., Saari, J. C., Jacobson, S. G., Lubiński, W., Feun, L. G., & Alexander, K. R. (1993) · PubMed · Cited by 225
The Mechanisms of hsp27 Antibody-Mediated Apoptosis in Retinal Neuronal Cells
Tezel, G., & Wax, M. B. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-10-03552.2000 · Cited by 197
The Occurrence of Serum Autoantibodies against Enolase in Cancer-Associated Retinopathy
Adamus, G., Aptsiauri, N., Guy, J., Heckenlively, J., Flannery, J., & Hargrave, P. A. (1996) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1996.0021 · Cited by 165
Self-citationPhotoreceptor Degeneration: Possible Autoimmune Disorder
Keltner, J. L. (1983) · Archives of Ophthalmology · doi:10.1001/archopht.1983.01040010564006 · Cited by 163
Adamus, G., Machnicki, M., & Seigel, G. M. (1997) · PubMed · Cited by 132
Self-citationAntibodies to Recoverin Induce Apoptosis of Photoreceptor and Bipolar Cells
Adamus, G., Machnicki, M., Elerding, H., Sugden, B., Blocker, Y., & Fox, D. A. (1998) · Journal of Autoimmunity · doi:10.1006/jaut.1998.0221 · Cited by 129
Self-citationLei, B., Bush, R. A., Milam, A. H., & Sieving, P. A. (2000) · PubMed · Cited by 119
Recoverin-associated retinopathy: a clinically and immunologically distinctive disease
Whitcup, S. M., Vistica, B. P., Milam, A. H., Nussenblatt, R. B., & Gery, I. (1998) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(98)00149-4 · Cited by 119
Cited by
Paraneoplastic Syndromes Involving the Nervous System
Darnell, R. B., & Posner, J. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023009 · Cited by 1,062
Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force
Titulaer, M. J., Soffietti, R., Dalmau, J., Gilhus, N. E., Giometto, B., Graus, F., Grisold, W., Honnorat, J., Sillevis Smitt, P. A. E., Tanasescu, R., et al. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03220.x · Cited by 526
The Role of Anti-α-Enolase Autoantibodies in Pathogenicity of Autoimmune-Mediated Retinopathy
MAGRYS, A., ANEKONDA, T., REN, G., & ADAMUS, G. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-006-9065-8 · Cited by 95
Self-citationJoachim, S. C., Bruns, K., Lackner, K. J., Pfeiffer, N., & Grus, F. H. (2007) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-006-0429-9 · Cited by 60
Adamus, G. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.672444 · Cited by 16
Self-citation
Metadata
- Authors
- Adamus, G., Ren, G., & Weleber, R. G.
- Venue
- BMC Ophthalmology
- Published
- 2004-06-04
- Volume
- 4
- Issue
- 1
- Pages
- 5-5
- ISSN
- 1471-2415 (ISSN-L)
- OpenAlex
- W1585495565
- Cited by
- 254
- References
- 25
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. https://app.cochat.ai/papers/10.1186/1471-2415-4-5
- The paper
- Adamus, G., Ren, G., & Weleber, R. G. (2004). Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmology. https://doi.org/10.1186/1471-2415-4-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.